Childhood cancers trials in Taiwan
30 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
- Where
- Changhua, Kaohsiung City, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 15 years and over
- People
- 800 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06079671 · EU 2023-504374-38-00 - Phase 2Taking peopleA Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
- Where
- Taipei
- Age
- 12 years to 17 years
- People
- 15 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07700758 · EU 2025-524515-37-00 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Taoyuan
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peopleA Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Where
- Taichung, Tainan, Taipei
- Age
- 12 years and over
- People
- 840 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05384626 · EU 2024-514266-39-00 - Phase 3Taking peopleA Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
- Where
- Taichung, Tainan, Taipei, Taoyuan
- People
- 200 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05862285 · EU 2023-504263-16-00 - Phase 1/2Taking peopleA Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
- Where
- Taichung, Tainan, Taipei
- Age
- 2 years and over
- People
- 420 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04811560 · EU 2023-506581-31-00 - Phase 1/2Taking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Taipei
- Age
- 6 months to 25 years
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - Phase 1/2Taking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Taichung, Taipei
- Age
- 12 years and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - Phase 1/2Taking peopleSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
- Where
- Taipei
- Age
- 1 year to 30 years
- People
- 50 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07387926 - Phase 2Taking peopleONO-4538 Phase II Rollover Study (ONO-4538-98)
- Where
- Kaohsiung City, New Taipei City, Tainan, Taipei, Taoyuan
- Age
- 16 years and over
- People
- 70 worldwide
- Run by
- Ono Pharmaceutical Co., Ltd.
See details and how to joinNCT04566380 - Phase 1/2Taking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Kaohsiung City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 12 years and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - No phaseTaking peopleLong-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy
- Where
- Kaohsiung, Tainan, Taipei
- People
- 49
- Run by
- Pell Bio-Med Technology Co., Ltd.
See details and how to joinNCT05377307 - Phase 1/2Taking peopleA Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Where
- Taiwan
- Age
- 1 month to 17 years
- People
- 50 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06941272 · EU 2024-518771-66-00 - Phase 1Taking peopleDinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma
- Where
- Taipei, Taoyuan
- Age
- 1 year to 30 years
- People
- 30
- Run by
- Chang Gung Memorial Hospital
See details and how to joinNCT07688252 - Phase 1Taking peopleA Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Taipei
- Age
- 6 months to 17 years
- People
- 18 worldwide
- Run by
- AbbVie
See details and how to joinNCT07306832 - Phase 1/2Taking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Taipei
- Age
- Up to 25 years
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - Phase 1/2Taking peopleA Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Where
- Taichung, Tainan, Taipei
- Age
- 12 years and over
- People
- 359 worldwide
- Run by
- Nuvalent Inc.
See details and how to joinNCT05118789 · EU 2024-511793-71-00 - No phaseTaking peopleEfficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual Health
- Where
- Taipei
- Age
- 7 years and over
- People
- 120
- Run by
- National Defense Medical University, Taiwan
See details and how to joinNCT07805096 - No phaseTaking peopleOne-Page Truth-Telling Aid for Cancer Disclosure
- Where
- Taoyuan
- People
- 400
- Run by
- Chang Gung University
See details and how to joinNCT07730164 - No phaseEnrolling by invitationLong-term Study to Evaluate Safety and Persistence of GF-CART01
- Where
- Taipei
- People
- 18
- Run by
- GenomeFrontier Therapeutics TW Co., Ltd.
See details and how to joinNCT06985576 - No phaseTaking peopleBlastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
- Where
- Taichung
- People
- 200 worldwide
- Run by
- Immune Oncology Research Institute
See details and how to joinNCT05430971 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Taiepi, Tainan, Taipei
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Taichung, Tainan, Taipei
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseNot yet taking people in TaiwanThe Role of Blood Perfusion in Cervical Cancer, Cervical Intraepithelial Neoplasm and Ovarian Cancer Patients
- Where
- New Taipei City
- People
- 100
- Run by
- Far Eastern Memorial Hospital
See details and how to joinNCT07385976 - No phaseTaking peopleCirculating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT
- Where
- Taoyuan City
- Age
- 18 months to 90 years
- People
- 100
- Run by
- Chang Gung Memorial Hospital
See details and how to joinNCT07296250